Home > Insider Trading > Filing (0000789132-13-000127)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
789132	Spectranetics Corp	SPNC	Electromedical & Electrotherapeutic Apparatus (3845)	840997049

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1396263	A Wade Bowe	9965 Federal Drive Colorado Springs CO 80921	Vice President R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Spnc Common Stock	Acquisiton	2013-11-01	16	$5.50	19,152	No	4	M	Direct
Spnc Common Stock	Acquisiton	2013-11-01	6,656	$10.65	25,808	No	4	M	Direct
Spnc Common Stock	Acquisiton	2013-11-01	7,500	$2.74	33,308	No	4	M	Direct
Spnc Common Stock	Disposition	2013-11-01	10,937	$20.73	22,371	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Spnc Common Stock	SPNC Stock Option	Disposition	2013-11-01	16	$0.00	16	$5.50
Spnc Common Stock	SPNC Stock Option	Disposition	2013-11-01	6,656	$0.00	6,656	$10.65
Spnc Common Stock	SPNC Stock Option	Disposition	2013-11-01	7,500	$0.00	7,500	$2.74

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2015-01-04	No	4	M	Direct
13,344	2017-03-20	No	4	M	Direct
15,000	2018-12-08	No	4	M	Direct

Footnotes

Sold pursuant to Mr. Bowe's 10b5-1 plan dated June 5, 2013
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.65 to $20.75, inclusive. The reporting person undertakes to provide to The Spectranetics Corporation, any security holder of The Spectranetics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Grant date 1/4/2005. Options are on a 4 year, 100% vesting schedule; 25% vested on 1/4/2006; 6.25% vested each calendar quarter thereafter. 100% fully vested on 1/4/2009. Options expire at the end of 10 years or on 1/4/2015.
Grant date 3/20/2007. Options are on a 4 year, 100% vesting schedule; 25% vested on 3/20/2008; 6.25% vested each calendar quarter thereafter. 100% fully vested on 3/20/2011. Options expire at the end of 10 years or on 3/20/2017.
Grant date 12/8/2008. Options vested upon the Company's stock price achieving $9.00 per share and a four year vesting schedule. Options were fully vested on 12/8/2012. Options expire at the end of 10 years or on 12/8/2018.